XYLOCAINE Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Xylocaine, and when can generic versions of Xylocaine launch?
Xylocaine is a drug marketed by Astrazeneca, Fresenius Kabi Usa, Epic Pharma Llc, and Dentsply Pharm. and is included in fourteen NDAs.
The generic ingredient in XYLOCAINE is epinephrine; lidocaine hydrochloride. There are twenty-one drug master file entries for this compound. Eleven suppliers are listed for this compound. Additional details are available on the epinephrine; lidocaine hydrochloride profile page.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for XYLOCAINE?
- What are the global sales for XYLOCAINE?
- What is Average Wholesale Price for XYLOCAINE?
Summary for XYLOCAINE
US Patents: | 0 |
Applicants: | 4 |
NDAs: | 14 |
Finished Product Suppliers / Packagers: | 8 |
Raw Ingredient (Bulk) Api Vendors: | 131 |
Clinical Trials: | 159 |
Patent Applications: | 4,993 |
Drug Prices: | Drug price information for XYLOCAINE |
What excipients (inactive ingredients) are in XYLOCAINE? | XYLOCAINE excipients list |
DailyMed Link: | XYLOCAINE at DailyMed |
Recent Clinical Trials for XYLOCAINE
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
CHU de Reims | N/A |
Vrije Universiteit Brussel | Phase 4 |
Centre hospitalier de l'Université de Montréal (CHUM) | Phase 4 |
Pharmacology for XYLOCAINE
Drug Class | Amide Local Anesthetic Antiarrhythmic Catecholamine alpha-Adrenergic Agonist beta-Adrenergic Agonist |
Mechanism of Action | Adrenergic alpha-Agonists Adrenergic beta-Agonists |
Physiological Effect | Local Anesthesia |